Moore; Joel D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Moore; Joel D..The latest application filed is for "difluoromethyl-containing macrocyclic compounds as hepatitis c virus inhibitors".

Company Profile

0.16.14

Moore; Joel D. - Lexington MA
Moore; Joel D. - Somerville MA
Moore; Joel D. - Bloomington MN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinoxalinyl derivatives Grant 8,962,551 - Niu , et al. February 24, 2	2015-02-24
Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors Grant 8,809,264 - Niu , et al. August 19, 2	2014-08-19
Macrocyclic hepatitis C virus serine protease inhibitors Grant 8,501,681 - Niu , et al. August 6, 2	2013-08-06
Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors Grant 8,383,583 - Moore , et al. February 26, 2	2013-02-26
C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors Grant 8,263,549 - Moore , et al. September 11, 2	2012-09-11
Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors Grant 8,211,891 - Gai , et al. July 3, 2	2012-07-03
Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 protease Grant 8,030,307 - Moore , et al. October 4, 2	2011-10-04
Hydrazide-containing hepatitis C serine protease inhibitors Grant 7,906,513 - Moore , et al. March 15, 2	2011-03-15
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors Grant 7,718,612 - Moore , et al. May 18, 2	2010-05-18
Difluoromethyl-containing Macrocyclic Compounds As Hepatitis C Virus Inhibitors App 20090274657 - Gai; Yonghua ; et al.	2009-11-05
Acylaminoheteroaryl hepatitis C virus protease inhibitors Grant 7,605,126 - Niu , et al. October 20, 2	2009-10-20
Phosphorus-containing hepatitis C serine protease inhibitors Grant 7,582,605 - Moore , et al. September 1, 2	2009-09-01
Quinoxalinyl Derivatives App 20090180981 - Niu; Deqiang ; et al.	2009-07-16
Bicyclic, C5-substituted Proline Derivatives As Inhibitors Of The Hepatitis C Virus Ns3 Protease App 20090180983 - Moore; Joel D. ; et al.	2009-07-16
C5-substituted, Proline-derived, Macrocyclic Hepatitis C Serine Protease Inhibitors App 20090175822 - MOORE; JOEL D. ; et al.	2009-07-09
Macrocyclic, Pyridazinone-containing Hepatitis C Serine Protease Inhibitors App 20090123425 - Moore; Joel D. ; et al.	2009-05-14
Pyridazinonyl Macrocyclic Hepatitis C Serine Protease Inhibitors App 20090035272 - Moore; Joel D. ; et al.	2009-02-05
Acyclic, Pyridazinone-derived Hepatitis C Serine Protease Inhibitors App 20090035267 - Moore; Joel D. ; et al.	2009-02-05
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors App 20090005387 - Niu; Deqiang ; et al.	2009-01-01
Hydrazide-containing Hepatitis C Serine Protease Inhibitors App 20080269228 - MOORE; JOEL D. ; et al.	2008-10-30
N-functionalized Amides As Hepatitis C Serine Protease Inhibitors App 20080267917 - Niu; Deqiang ; et al.	2008-10-30
Phosphorus-containing hepatitis C serine protease inhibitors App 20080039375 - Moore; Joel D. ; et al.	2008-02-14
Acylaminoheteroaryl hepatitis C virus protease inhibitors App 20080039470 - Niu; Deqiang ; et al.	2008-02-14
Macrocyclic Hepatitis C Virus Serine Protease Inhibitors App 20080008681 - Niu; Deqiang ; et al.	2008-01-10
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors App 20070299078 - Niu; Deqiang ; et al.	2007-12-27
Method for water purification Grant 5,062,958 - Bateson , et al. November 5, 1	1991-11-05

Company Registrations

SEC

0001411210

Moore Joel D

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.